eSUN Partners with RESA to Broaden 3D printed Insoles Market 3D Scanning Sevices

eSUN Partners with RESA to Broaden 3D printed Insoles Market 3D Scanning Sevices

On August 10th, Shenzhen eSUN Industrial Co., Ltd. Signed a Joint Venture with RESAWearables, Inc. to set up Shenzhen Resun Healthcare Technology Co., Ltd. This new joint venture in Shenzhen will offer 3D laser foot scanning, CAD design and 3D printing kiosks for RESA globally and in the domestic Chinese market as well. It will also provide custom orthotics and terminal sales for the general public. The joint venture will enter Chinese medical-grade footwear market

Renishaw and Aeromet partner to optimize A20X high-performance alloy Aerospace

Renishaw and Aeromet partner to optimize A20X high-performance alloy Aerospace

Renishaw and Aeromet International Limited are collaborating to establish additive manufacturing process parameters and material properties for Aeromet’s A20X high-performance alloy. Following a successful debut at the Paris Air Show, last month, the two companies are working together to optimize the processing techniques for the high-performance alloy on Renishaw metal additive manufacturing (AM) systems. They are also investigating a range of heat treatment regimes to deliver optimum properties in additively manufactured components. The results of these developments will be made available to Renishaw and Aeromet customers.

3b73724283cad9c09378a2b3bcb98e33.jpg

Markforged introduces new X3, X5 and X7 composite 3D printers 3D Printer Hardware

Markforged is one of those companies that – like so many others in the 3D printing industry – is so much focused on the quality and the engineering of the products it develops that it does not particularly care about letting the world know they exist. Luckily we occasionally find out about their latest product launch: not just any launch either, but three new, industrial grade composite 3D printing systems known as X3, X5 and X7.

Human 3D Blood-Vessel-On-a-Chip Model Shows Cell Migration for Fibrotic Diseases AM Software

Human 3D Blood-Vessel-On-a-Chip Model Shows Cell Migration for Fibrotic Diseases AM Software

A team of scientists at the Wyss Institute at Harvard University and Boston University has created a 3D blood-vessel-on-a-chip model to investigate endothelial barrier failure, and found that inflammation disrupts the connections between endothelial cells and mural cells, causing the mural cells to retract or even detach from their usual position surrounding blood vessels and leading to further leakage.

Human 3D Blood-Vessel-On-a-Chip Model Shows Cell Migration for Fibrotic Diseases AM Software

Human 3D Blood-Vessel-On-a-Chip Model Shows Cell Migration for Fibrotic Diseases Bioprinting

A team of scientists at the Wyss Institute at Harvard University and Boston University has created a 3D blood-vessel-on-a-chip model to investigate endothelial barrier failure, and found that inflammation disrupts the connections between endothelial cells and mural cells, causing the mural cells to retract or even detach from their usual position surrounding blood vessels and leading to further leakage.

8005f60c63e224eadbc67ceb4b95a93e.jpg

voxeljet down 18.2% in Q2, optimistic on new HSS systems and service revenues AM Industry

Some might have missed it but voxeljet is moving fast on its 3D printing capabilities as binder jetting technology as a whole is experiencing a kind of a renaissance. This does not yet reflect on the sale of voxeljet systems for the latest fiscal quarter, where the company reported revenues down 18.2% mostly due to decreasing system revenues (-33.4%) to €2.6 million. It does, however, make the company optimistic for the near future. As voxeljet CEO Dr. Ingo Ederer clearly stated:

f0e122635cfb6f2af01a50c445479ee9.jpg

BYU Researchers 3D Print First Truly Microfluidic “Lab On a Chip” Device Research & Education

As reported by Todd Hollingshead on the official University blog, researchers at Brigham Young University (BYU) are the first to 3D print a viable microfluidic device small enough to be effective at a scale much less than 100 micrometers. Microfluidic devices are tiny chips that can sort out disease biomarkers, cells and other small structures in samples like blood by using microscopic channels incorporated into the devices.